BRK-A vs ELV
Berkshire Hathaway Inc. and Elevance Health, Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | BRK-A | ELV |
|---|---|---|
| Revenue | $247.2B | $199.1B |
| Net income | $67.0B | $5.7B |
| Gross margin | — | 89.4% |
| Net margin | 27.1% | 2.8% |
| Return on equity | 9.8% | 13.3% |
| Diluted EPS | — | $25.21 |
| Dividend / share | — | $5.92 |
| Payout ratio | — | 27.0% |
| Free cash flow | $25.0B | $3.2B |
| Equity | $717.4B | $43.9B |
| Net debt / equity | — | 0.51× |
| Current ratio | — | 1.54× |
| Revenue CAGR 5y | 8.2% | 10.3% |
| Profit CAGR 5y | 9.5% | 4.4% |
BRK-A bills 1.2× the revenue of ELV, and keeps more of each dollar of revenue as profit (27.1% against 2.8%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
10 years side by side
| Fiscal year | BRK-A | ELV |
|---|---|---|
| FY2025 | $247.2B | $199.1B |
| FY2024 | $249.7B | $177.0B |
| FY2023 | $254.9B | $171.3B |
| FY2022 | $207.8B | $156.6B |
| FY2021 | $191.3B | $138.6B |
| FY2020 | $166.7B | $121.9B |
| FY2019 | $176.5B | $104.2B |
| FY2018 | $175.4B | $92.1B |
| FY2017 | $239.9B | $90.0B |
| FY2016 | $215.1B | $84.9B |
Net income by year
Bottom line
| Fiscal year | BRK-A | ELV |
|---|---|---|
| FY2025 | $67.0B | $5.7B |
| FY2024 | $89.0B | $6.0B |
| FY2023 | $96.2B | $6.0B |
| FY2022 | $-22.8B | $5.9B |
| FY2021 | $89.9B | $6.2B |
| FY2020 | $42.5B | $4.6B |
| FY2019 | $81.4B | $4.8B |
| FY2018 | $4.0B | $3.8B |
| FY2017 | $44.9B | $3.8B |
| FY2016 | $24.1B | $2.5B |
Advertisement
AdSense · Rectangle 336×280